[1] 中华人民共和国国家卫生健康委员会.中国结直肠癌诊疗规范(2020年版)[J].中国实用外科杂志,2020,40(6):601-625. [2] 郭磊,朱海杭,周步良.结肠直肠癌与胆汁酸代谢、肠道菌群分布水平的相关性研究[J].实用临床医药杂志,2019,23(2):95-96. [3] Sayin S I,Wahlstrom A,Felin J,et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid,a naturally occurring FXR antagonist[J].Cell Metab,2013,17(2):225-235. [4] Nguyen T T,Ung T T,Kim N H,et al.Role of bile acids in colon carcinogenesis[J].World Clin Cases,2018,6(13):577-588. [5] 徐仁应,卞玉海,万燕萍,等.短链脂肪酸与结直肠肿瘤细胞凋亡关系的研究[J].肠外与肠内营养,2013,20(5):259-262. [6] Ha Y H,Park D G.Effects of DCA on cell cycle proteins in colonocytes[J].Korean Soc Coloproctol,2010,26(4):254-259. [7] Wang L,Shannar A,Wu R,et al.Butyrate drives metabolic rewiring and epigenetic reprogramming in human colon cancer cells[J].Mol Nutr Food Res,2022,66(12):2200028. [8] Park M,Kwon J,Shin H J,et al.Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patientderived organoids[J].Int Oncol,2020,57(6):1307-1318. [9] Bailey A M,Zhan L,Maru D,et al.FXR silencing in human colon cancer by DNA methylation and KRAS signaling[J].Am Physiol Gastrointest Liver Physiol,2014,306(1):G48-G58. [10] Fu T,Coulter S,Yoshihara E,et al.FXR regulates intestinal cancer stem cell proliferation[J].Cell,2019,176(5):1098-1112. [11] Haque S,Morris J C.Transforming growth factor-beta:a therapeutic target for cancer[J].Hum Vaccin Immunother,2017,13(8):1741-1750. [12] Sears C L,Garrett W S.Microbes,microbiota,and colon cancer[J].Cell Host Microbe,2014,15(3):317-328. [13] Rezasoltani S,Yadegar A,Asadzadeh A H,et al.Modulatory effects of gut microbiome in cancer immunotherapy:a novel paradigm for blockade of immune checkpoint inhibitors[J].Cancer Med,2021,10(3):1141-1154. [14] Montalban-arques A,Katkeviciute E,Busenhart P,et al.Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumors[J].Cell Host Microbe,2021,29(10):1573-1588.
2023, Vol. 29 
冀公网安备13080202000677号